If you need more lookups,
subscriptions start at $34 USD/month.
Andrew Pierce Location
United Kingdom
Andrew Pierce Work
2026 -now Chief Scientific Officer @
2026 -now Director @
2024 -2026 Senior Vice President - Discovery and Development @
2020 -2024 Vice President - Translational Biology @
2014 -2020 Associate Director - Translational Medicine Oncology @
2011 -2014 Senior Scientist - Translational Medicine Oncology @
2010 -2011 Oncology Biomarker Analyst @
2003 -2011 Assistant Professor @
1997 -2003 Senior Postdoctoral Research Associate @
1995 -1997 Postdoctoral Research Associate @
Andrew Pierce Education
The University of North Carolina at Chapel Hill
Ph.D. (molecular genetics)
1990-1995
University of Toronto - University of Trinity College
B.Sc. (honors) (Molecular and Cellular Biology)
1986-1990
Andrew Pierce Skills
Biomarkers
Cancer
Cell Biology
drug development
Translational Research
Translational Medicine
Molecular Biology
Molecular Genetics
Drug Discovery
Therapeutics
Oncology
Immunology
Cancer Research
Translational Science
Targeted Therapies
Genetics
Biotechnology
Monoclonal Antibodies
Clinical Research
Antibodies
Clinical Development
Clinical Trials
Assay Development
Flow Cytometry
Personalized Medicine
Pharmaceutical Industry
PowerPoint
Science
Healthcare
Public Speaking
Management
Biochemistry
Andrew Pierce Summary
Andrew Pierce, based in United Kingdom, is currently a Chief Scientific Officer at Refoxy Pharma. Andrew Pierce brings experience from previous roles at Paralog Ltd, Owkin, Crescendo Biologics Limited and AstraZeneca. Andrew Pierce holds a 1990 - 1995 Ph.D. in molecular genetics @ The University of North Carolina at Chapel Hill. With a robust skill set that includes Biomarkers, Cancer, Cell Biology, drug development, Translational Research and more. Andrew Pierce has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Andrew Pierce?
Find contact details for 700 million professionals.